US2016194289A1PendingUtilityA1
Process for drying bendamustine hydrochloride monohydrate
Est. expiryMar 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
C07D 235/16A61P 35/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.
Claims
exact text as granted — not AI-modified1 .- 18 . (canceled)
19 . Dry bendamustine hydrochloride monohydrate produced by the method of claim 1 .
20 . Dry bendamustine hydrochloride monohydrate, containing less than 0.15%, as determined by HPLC area %, of monohydroxy-bendamustine.
21 . The dry bendamustine hydrochloride monohydrate of claim 20 , containing less than 0.05%, as determined by HPLC area %, of monohydroxy-bendamustine.
22 . Dry bendamustine hydrochloride monohydrate, substantially free of any other physical form of bendamustine hydrochloride.
23 . Dry bendamustine hydrochloride monohydrate, substantially free of anhydrous bendamustine hydrochloride.Join the waitlist — get patent alerts
Track US2016194289A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.